CMS modified NCD 151 governing TENS and NMES supply coverage, effective March 7, 2026. Here's what billing teams need to do.
The Centers for Medicare & Medicaid Services updated NCD 151, the National Coverage Determination governing supplies used in the delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES). This modification clarifies when form-fitting conductive garments qualify as covered alternatives to conventional electrodes, adhesive tapes, and lead wires. The policy does not list specific CPT or HCPCS codes in this version — which means your documentation and medical necessity justification carry all the weight when a claim hits a Medicare Administrative Contractor's desk.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Supplies Used in the Delivery of TENS and NMES |
| Policy Code | NCD 151 |
| Change Type | Modified |
| Effective Date | March 7, 2026 |
| Impact Level | Medium |
| Specialties Affected | Pain management, physical medicine & rehabilitation, neurology, DME suppliers |
| Key Action | Audit your conductive garment claims for all five medical necessity criteria before billing |
CMS TENS and NMES Coverage Criteria and Medical Necessity Requirements 2026
The CMS TENS and NMES coverage policy under NCD 151 covers form-fitting conductive garments as a supply alternative — but only under specific, narrow conditions. Meeting just one or two of the criteria below is not enough. Your documentation must show that the garment is the right tool for this specific patient.
A form-fitting conductive garment is covered when three threshold requirements are met. First, the garment must have FDA marketing permission or approval. Second, a physician must prescribe it specifically for covered TENS or NMES treatment. Third, at least one of the five clinical indications below must apply.
The five clinical indications are:
| # | Covered Indication |
|---|---|
| 1 | The treatment area is too large or involves too many sites, and stimulation frequency makes conventional electrodes, adhesive tapes, and lead wires impractical. |
| 2 | The sites to be stimulated are inaccessible for chronic intractable pain treatment using conventional electrodes, adhesive tapes, and lead wires. |
| 3 | The patient has a documented skin condition that prevents use of conventional electrodes, adhesive tapes, and lead wires. |
| 4 | Electrical stimulation is required beneath a cast — either to treat disuse atrophy (with intact nerve supply) or to treat chronic intractable pain. |
| 5 | The patient needs rehabilitation strengthening following an injury, documented by a written rehabilitation plan, with intact nerve supply to the muscle. |
Every one of these is specific. "The patient finds electrodes uncomfortable" does not meet the standard. Your clinical notes need to name the documented medical condition, the inaccessible site, or the written rehabilitation plan — whichever applies.
There's also a separate prior authorization-adjacent gate for TENS trial periods. During the TENS trial period defined in §160.3, a conductive garment is not covered unless the patient had a documented skin problem before the trial started and the Medicare Administrative Contractor's medical consultants confirm medical necessity. This is a harder bar. Don't bill the garment during a TENS trial unless both conditions are clearly documented before the effective date of service.
The reimbursement exposure here is real. If your team bills for conductive garments without documentation of one of these five indications, you're looking at claim denial — not just a request for more information, but a coverage-based denial that's harder to appeal.
CMS TENS and NMES Exclusions and Non-Covered Indications
The coverage policy draws a hard line on conductive garments used with TENS devices during trial periods. Unless the patient had a documented skin problem before the trial started, the garment is not covered during that window. Full stop.
Beyond the trial-period restriction, patient preference or general convenience is not a covered indication. The policy requires that conventional electrodes, adhesive tapes, and lead wires be genuinely unworkable — not merely less comfortable or less convenient. If your physician's order says the patient "prefers" the garment, that documentation will not hold up under a Medicare medical necessity review.
The policy is also narrower than it looks on disuse atrophy and rehabilitation cases. For both indications, intact nerve supply to the muscle is a hard requirement. If nerve supply is not intact, neither NMES for disuse atrophy nor rehabilitation strengthening qualifies for coverage. Document nerve supply status in the clinical record before billing.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Large treatment area or frequent stimulation making conventional electrodes impractical | Covered | Not specified in NCD 151 | Physician prescription required; FDA-approved garment required |
| Chronic intractable pain — sites inaccessible to conventional electrodes | Covered | See §§160.3, 160.13, 160.27 | Cross-reference TENS NCDs for intractable pain |
| Documented skin condition precluding conventional electrodes | Covered | Not specified in NCD 151 | Skin condition must be documented in medical record before service date |
| Stimulation beneath a cast — disuse atrophy (intact nerve supply) | Covered | See §150.4 | Nerve supply to muscle must be documented as intact |
| Stimulation beneath a cast — chronic intractable pain | Covered | See §§160.3, 160.13, 160.27 | Physician prescription and FDA approval required |
| Rehabilitation strengthening post-injury (intact nerve supply, written plan) | Covered | See §150.4 | Written rehabilitation plan required; nerve supply must be intact |
| Conductive garment during TENS trial period — no prior skin problem | Not Covered | See §160.3 | Excluded unless skin problem pre-existed trial start AND MAC medical consultant approves |
| Use based on patient preference or convenience | Not Covered | N/A | Conventional electrodes must be genuinely unworkable |
| NMES — nerve supply not intact | Not Covered | See §150.4 | Applies to both disuse atrophy and rehabilitation strengthening indications |
CMS TENS and NMES Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 is already here. If your team bills conductive garments for TENS or NMES, act now.
| # | Action Item |
|---|---|
| 1 | Audit your current conductive garment claims. Pull every claim for conductive garments billed since January 1, 2026. Confirm each has documentation supporting one of the five covered indications. Flag any claim where the documentation only references patient preference or general discomfort. |
| 2 | Update your intake templates to capture the five indications. Your clinical documentation workflow needs to prompt physicians to specify which indication applies before the claim is generated. A generic "medically necessary" notation is not enough under this coverage policy. |
| 3 | Verify FDA approval status for every garment you bill. The policy requires FDA marketing permission or approval. If you stock a garment that lacks current FDA clearance, it is not billable under this NCD — regardless of how well it works clinically. |
| 4 | Train your ordering physicians on the TENS trial-period restriction. If a physician initiates a TENS trial and wants to use a conductive garment from day one, the patient needs a documented skin problem that pre-dates the trial. Confirm your physicians know to record this finding before the trial starts, not after the claim is denied. |
| 5 | Cross-reference your conductive garment billing with NCD §150.4 (NMES), §160.3, §160.13, and §160.27 (TENS for chronic intractable pain). NCD 151 does not stand alone. Coverage for the underlying TENS or NMES treatment must also be established before the garment is covered. Billing the garment on a claim where the underlying therapy isn't covered will trigger a denial. |
| 6 | Contact your Medicare Administrative Contractor before billing garments during any active TENS trial. The policy requires MAC medical consultant approval in this scenario. Don't assume approval — get it in writing before submitting the claim. |
| 7 | Document rehabilitation plans before billing the rehabilitation strengthening indication. A written plan of rehabilitation is a hard requirement for indication five. If the plan isn't in the chart before the date of service, the garment isn't covered that day. |
If your mix includes a high volume of TENS and NMES patients with complex wound or skin conditions — or post-injury rehabilitation patients — loop in your compliance officer before March 31, 2026. The documentation requirements here are specific enough that a pre-billing audit is worth the time.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for TENS and NMES Supplies Under NCD 151
Covered Codes (When Selection Criteria Are Met)
This policy does not list specific CPT or HCPCS codes. CMS did not include code-level detail in the NCD 151 policy document. Your billing team should consult the HCPCS code set for conductive garment supply codes and confirm coverage through your Medicare Administrative Contractor.
For related coverage determinations that cross-reference NCD 151, see:
| Reference | Description |
|---|---|
| NCD §150.4 | NMES in the Treatment of Disuse Atrophy |
| NCD §160.3 | TENS — Use in the Treatment of Chronic Intractable Pain |
| NCD §160.7 | Assessing Patient Suitability for Electrical Nerve Stimulation (ENS) |
| NCD §160.12 | Neuromuscular Electrical Stimulation (NMES) |
| NCD §160.27 | TENS — Additional Coverage Conditions |
A Note on Code Lookup for TENS and NMES Billing
Because NCD 151 governs supplies rather than the TENS or NMES procedure itself, TENS and NMES billing typically involves HCPCS Level II codes for durable medical equipment and supplies. Your DME MAC or a HCPCS code reference will be the right starting point. Do not rely on unlisted or miscellaneous supply codes unless you've confirmed no specific HCPCS code exists for the garment you're billing — miscellaneous codes invite additional documentation requests and slow your reimbursement cycle.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.